This is one of the most common decisions pharma companies face as they scale content needs. Building an in house team feels like more control, while working with an external medical writing agency feels like more flexibility. Neither answer is universally correct.
The right choice really depends on volume, therapeutic breadth, and how predictable your content needs are throughout the year. A company with steady, focused output has very different needs than one managing multiple product launches across varied therapeutic areas.
What Are The Real Advantages Of An In House Team?
In house writers develop deep familiarity with your specific brand voice, internal approval processes, and product history over time. That institutional knowledge builds gradually and can be genuinely valuable for ongoing, predictable content needs across a stable portfolio.
That said, in house teams struggle with sudden volume spikes. Hiring takes months, and a team sized for average workload inevitably falls behind during launches or congress season, when demand temporarily surges well beyond normal capacity.
Where Does A Medical Writing Agency Offer Clear Advantages?
Flexibility is the biggest one. An external agency can scale support up during peak periods without the lengthy hiring process an in house expansion requires, absorbing sudden demand spikes far more efficiently than a fixed internal team ever could.
Access to broader therapeutic expertise matters too. A provider like medical writing agency brings teams of medical writers, scientific directors, and clinicians spanning multiple specialties, something a smaller in house team simply can’t match across every therapeutic area a growing pipeline might touch.
How Does AI Medical Writing Change This Comparison?
This is where things get genuinely interesting. Agencies using properly trained AI medical writing tools can offer both the flexibility of external support and speed that rivals or exceeds what even a well staffed in house team could deliver during peak demand.
A workflow like AI medical writing, built and trained by medical writers, scientific directors, and clinicians, essentially closes the gap that used to exist between in house familiarity and external flexibility, since accelerated drafting speeds up onboarding to new brand voice and requirements considerably.
A Scenario Worth Considering
Imagine a company with a stable in house team handling routine content, but facing an unexpected acquisition that doubles their therapeutic pipeline overnight. Scaling the in house team fast enough simply isn’t realistic given typical hiring timelines.
Supplementing with external medical writing agency support during this transition, rather than rushing hiring decisions, protects quality while the in house team gradually grows to match the new scope. This hybrid approach often works better than an all or nothing choice.
Questions To Help Decide What Fits Your Brand
- How predictable is our content volume across the next twelve months?
- Do we have therapeutic gaps our current team can’t fully cover?
- Can we realistically scale hiring fast enough for upcoming launches?
Conclusion
There isn’t a universally right answer between in house teams and an external medical writing agency. Many successful brands actually use both, keeping a core in house team for consistency while leaning on external partners for flexibility during peak demand periods.
What matters most is being honest about your actual volume patterns and therapeutic breadth rather than defaulting to whichever option feels more comfortable. That honest assessment usually points clearly toward the right structure for your specific situation.
FAQs
Is it common for pharma brands to use both in house and agency support?
Yes, many brands use a hybrid model, keeping core content in house while using agencies for overflow or specialized therapeutic needs.
How quickly can an external agency scale up during a launch?
This varies by provider, but established agencies with mature processes can typically onboard new projects within days.
Does using AI medical writing reduce the need for in house writers?
Not entirely. It accelerates drafting, but human oversight and brand familiarity still matter for consistent quality.
